Biosimilar Therapeutic Peptides Market, Global Outlook and Forecast 2022-2028

0
10

Biosimilar therapeutic peptides are used as replacement therapies which supplements peptide hormones when the endogenous levels tend to decrease.
This report contains market size and forecasts of Biosimilar Therapeutic Peptides in Global, including the following market information:
Global Biosimilar Therapeutic Peptides Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Biosimilar Therapeutic Peptides market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Innovative Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biosimilar Therapeutic Peptides include Pfizer, GlaxoSmithKline, li Lilly and Company, Sanofi, Takeda Pharmaceuticals, Teva Pharmaceuticals, Amgen, AstraZeneca and Novartis AG and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biosimilar Therapeutic Peptides companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biosimilar Therapeutic Peptides Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Biosimilar Therapeutic Peptides Market Segment Percentages, by Type, 2021 (%)
Innovative
Generic
Global Biosimilar Therapeutic Peptides Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Biosimilar Therapeutic Peptides Market Segment Percentages, by Application, 2021 (%)
Cancer
Cardiovascular
Central Nervous Systems
Metabolic Disorders
Gastrointestinal Disorders
Dermatology
Others
Global Biosimilar Therapeutic Peptides Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Biosimilar Therapeutic Peptides Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biosimilar Therapeutic Peptides revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Biosimilar Therapeutic Peptides revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
GlaxoSmithKline
li Lilly and Company
Sanofi
Takeda Pharmaceuticals
Teva Pharmaceuticals
Amgen
AstraZeneca
Novartis AG
Novo Nordisk

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.